Ensign Peak Advisors’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $472K | Sell |
|
|||||
|
2025
Q2 | $502K | Hold |
|
|||||
|
2025
Q1 | $522K | Hold |
|
|||||
|
2024
Q4 | $396K | Hold |
|
|||||
|
2024
Q3 | $316K | Hold |
|
|||||
|
2024
Q2 | $601K | Hold |
|
|||||
|
2024
Q1 | $614K | Sell |
|
|||||
|
2023
Q4 | $745K | Hold |
|
|||||
|
2023
Q3 | $677K | Hold |
|
|||||
|
2023
Q2 | $885K | Hold |
|
|||||
|
2023
Q1 | $901K | Hold |
|
|||||
|
2022
Q4 | $853K | Buy |
|
|||||
|
2022
Q3 | $887K | Sell |
|
|||||
|
2022
Q2 | $1.07M | Hold |
|
|||||
|
2022
Q1 | $1.41M | Hold |
|
|||||
|
2021
Q4 | $1.11M | Sell |
|
|||||
|
2021
Q3 | $1.55M | Hold |
|
|||||
|
2021
Q2 | $1.68M | Hold |
|
|||||
|
2021
Q1 | $1.93M | Buy |
|
|||||
|
2020
Q4 | $1.51M | Buy |
|
|||||
|
2020
Q3 | $1.19M | Hold |
|
|||||
|
2020
Q2 | $1.04M | Hold |
|
|||||
|
2020
Q1 | $664K | Buy |
|
|||||
|
2019
Q4 | $421K | Buy |
|